Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
63°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
70.69
+2.21 (+3.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about DexCom, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
10 Worst Performing Large-Caps Last 12 Months
March 13, 2025
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via
Talk Markets
Topics
Stocks / Equities
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
March 11, 2025
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Which S&P500 stocks are moving on Monday?
March 10, 2025
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Via
Chartmill
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried
March 10, 2025
The company is facing a regulatory setback. But one analyst doesn't expect that to impact its upcoming, potential approval.
Via
Investor's Business Daily
DexCom Analysts Increase Their Forecasts After Q4 Earnings
February 14, 2025
Via
Benzinga
Earnings Scheduled For February 13, 2025
February 13, 2025
Via
Benzinga
Should You Buy DexCom Stock Before Feb. 13?
February 06, 2025
Via
The Motley Fool
Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings)
February 03, 2025
Via
Benzinga
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
March 10, 2025
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.
Via
Chartmill
DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
March 03, 2025
Based on technical and fundamental analysis of NASDAQ:DXCM we find: DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.
Via
Chartmill
3 Growth Stocks to Buy and Hold Forever
March 01, 2025
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 27, 2025
Via
Benzinga
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
February 27, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
February 26, 2025
Via
The Motley Fool
These S&P500 stocks are moving in today's pre-market session
February 19, 2025
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via
Chartmill
Insulet Earnings: What To Look For From PODD
February 19, 2025
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Via
StockStory
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
February 19, 2025
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.
Via
StockStory
What's going on in today's session: S&P500 movers
February 14, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Via
Chartmill
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
February 14, 2025
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.
Via
Benzinga
In today's session, there are S&P500 stocks with remarkable trading volume.
February 14, 2025
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via
Chartmill
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
February 14, 2025
Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Discover which S&P500 stocks are making waves on Friday.
February 14, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More
February 14, 2025
Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access.
Via
Benzinga
DexCom (DXCM) Q4 2024 Earnings Call Transcript
February 13, 2025
DXCM earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
DexCom: Revenue Up, EPS Misses Mark
February 13, 2025
DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short.
Via
The Motley Fool
DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue
February 13, 2025
Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 7.6% year on year to $1.11 billion. The company expects the full year’s...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations
February 13, 2025
Dexcom stock fell late Thursday after the company missed fourth-quarter profit expectations by a nickel per share.
Via
Investor's Business Daily
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
February 12, 2025
Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know.
Via
StockStory
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
February 10, 2025
Based on a technical and fundamental analysis of NASDAQ:DXCM we can say: DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via
Chartmill
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
February 03, 2025
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.